ArticleBMC musculoskeletal disorders2024

Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes.

Xianyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.